Aurinia Pharmaceuticals shows steady Lupkynis sales growth. Read more on AUPH's Q1 '25 earnings, management change and ...

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026MZE782 Phase 1 Healthy Volunteer ...

OCI N.V. retains a Hold rating as its focus on European nitrogen fertilizers, debt reduction, and improved market conditions ...

The annual production was mainly because of record throughput after the completion of the Tasiast 24k project in H2 2023. Quarter-over-quarter, the production was lower because of planned lower ...

Parkin’s ability to pay dividends is dependent on several factors, including the availability of distributable reserves, capital expenditure plans and other cash requirements ...

Company ended the quarter with US$16.4 million in cash Revenues of US$9.6M vs US$7.1M in 2023, a 35.2% increase YOY TORONTO, ONTARIO, April 09, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ ...

Gross margin improved by 1.9 point, reaching 53% over the year Positive EBITDA of €0.5 million, despite a decline in 2024 revenue to €57.1 million, compared with €82.5 million in 2023 Net ...

Australian politicians were gifted about A$245,000 ($147,000) in match tickets over nearly two years by the country's most ...

Q1 2025 revenue Quarterly activity Revenue: €180.1m, down 7.1% at CER1 and on a like-for-like basis2As expected, a first ...

SYDNEY - Australian politicians were gifted about A$245,000 ($147,000) in match tickets over nearly two years by the ...